HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dalakas, E. Articles by Plevris, J. N. Search for Related Content PubMed PubMed Citation Articles by Dalakas, E. Articles by Plevris, J. N.

Hematopoietic stem cell trafficking in liver injury

Evangelos Dalakas^*,1, Philip N. Newsome^*, David J. Harrison and John N. Plevris^*

^* Hepatology Unit, Chancellor's Building, The University of Edinburgh, Edinburgh, UK; and
MRC Centre for Inflammation Research, The University of Edinburgh, Medical School, Edinburgh, UK

¹Correspondence: Hepatology Unit, Chancellor's Building, The University of Edinburgh, 49 Little France Crescent, Edinburgh, EH16 4SB UK. E-mail: e.dalakas{at}ed.ac.uk

Bone marrow (BM) hematopoietic stem cells (HSCs) have been shown to facilitate regeneration in multiple nonhematopoietic tissues by either generating epithelial cells or altering the inflammatory response. Depending on injury type, the predominant mechanism of epithelial lineage regeneration occurs by spontaneous cell fusion or transdifferentiation. Irrespective of the mechanism, mobilization from the BM is a prerequisite. Mechanisms by which HSCs mobilize into damaged organs are currently under scrutiny. Murine and human studies have shown that the chemokine SDF-1 and its receptor CXCR4 participate in the mobilization of HSCs from BM and in the migration of HSCs to injured liver. SDF-1 is a potent HSC chemoattractant and is produced by the liver. Production is increased during liver injury leading to increased HSC migration to the liver, a finding diminished by neutralizing anti-CXCR4 antibodies. Additional factors have been implicated in the control of hepatic migration of HSCs such as IL-8, hepatocyte growth factor, and MMP-9. Matriceal remodeling is an essential component in HSC engraftment, and MMP-9 expression is increased in liver injury. This review focuses on the complex interaction of chemokines, adhesion molecules, and extracellular matrix factors required for successful migration and engraftment of HSCs into the liver.—Dalakas, E., Newsome, P. N., Harrison, D. J., Plevris, J. N. Hematopoietic stem cell trafficking in liver injury.

Key Words: migration • engraftment • SDF-1 • MMP-9

This article has been cited by other articles:

				F. Zeng, M.-j. Chen, D. A. Baldwin, Z.-j. Gong, J.-b. Yan, H. Qian, J. Wang, X. Jiang, Z.-r. Ren, D. Sun, et al. Multiorgan engraftment and differentiation of human cord blood CD34+Lin- cells in goats assessed by gene expression profiling PNAS, May 16, 2006; 103(20): 7801 - 7806. [Abstract] [Full Text] [PDF]